Oncolytics Biotech Inc
Price
FilingsNewest: 8-K, Other eventsSep 29 →Insiders10 insiders bought $363,232 in 14 open-market buys. No sales.→Financing →PeersClosest companies: APVO, CRVS, CRDF→
From the filings
Figures
- Net income
- −$33.3Mlast 12 months
- Operating cash flow
- −$22.7Mlast 12 months
- Cash and equivalents
- $4.1Mat the last balance sheet
- Shares outstanding
- 124.6M shareson issue